Pathalys Pharma
Latest round
- Series B
Last raised
- Aug 2024
Total raised
- $105M
Investors
- 8
About Pathalys Pharma
Based in North Carolina, US, and founded in 2021, Pathalys Pharma, Inc. provides treatment for end-stage renal disease. As of 2024, the company is headed by its CEO Neal Fowler. The company offers solutions for patients with end-stage kidney disease. Pathalys provides calcimimetics for the treatment of SHPT. By activating the calcium-sensing receptor, which is expressed in a variety of human organ tissues, calcimimetic is a medication that simulates the effects of calcium on tissues.
Who invested in Pathalys Pharma
8 investors across 2 rounds
See all investors in Pathalys Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pathalys Pharma
Who invested in Pathalys Pharma?
Pathalys Pharma has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pathalys Pharma raised?
Pathalys Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pathalys Pharma last raise money?
Pathalys Pharma's most recent round on record is a Series B, in Aug 2024.
What does Pathalys Pharma do?
Based in North Carolina, US, and founded in 2021, Pathalys Pharma, Inc.
Where is Pathalys Pharma headquartered?
Pathalys Pharma is headquartered in Raleigh, US.
Which VCs invest in companies like Pathalys Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pathalys Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pathalys Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.